Practical Approaches to Managing Patients With Moderate to Severe Alzheimer Disease

26
Practical Approaches to Managing Patients With Moderate to Severe Alzheimer Disease

TAGS:

description

Practical Approaches to Managing Patients With Moderate to Severe Alzheimer Disease. Program Goals. Patient Vignette: Part 1. Stages of Alzheimer Disease. Benefits of Staging Alzheimer Disease. Depression/Behavioral Disorders. Cholinesterase Inhibitors. - PowerPoint PPT Presentation

Transcript of Practical Approaches to Managing Patients With Moderate to Severe Alzheimer Disease

Page 1: Practical Approaches to Managing Patients With Moderate to Severe Alzheimer Disease

Practical Approaches to Managing Patients With Moderate to Severe

Alzheimer Disease

Page 2: Practical Approaches to Managing Patients With Moderate to Severe Alzheimer Disease
Page 3: Practical Approaches to Managing Patients With Moderate to Severe Alzheimer Disease

Program Goals

Page 4: Practical Approaches to Managing Patients With Moderate to Severe Alzheimer Disease

Patient Vignette: Part 1

Page 5: Practical Approaches to Managing Patients With Moderate to Severe Alzheimer Disease

Stages of Alzheimer Disease

Page 6: Practical Approaches to Managing Patients With Moderate to Severe Alzheimer Disease

Benefits of Staging Alzheimer Disease

Page 7: Practical Approaches to Managing Patients With Moderate to Severe Alzheimer Disease

Depression/Behavioral Disorders

Page 8: Practical Approaches to Managing Patients With Moderate to Severe Alzheimer Disease

Cholinesterase Inhibitors

Page 9: Practical Approaches to Managing Patients With Moderate to Severe Alzheimer Disease

N-methyl-D-aspartate receptor (NMDA) Receptor Antagonists

Page 10: Practical Approaches to Managing Patients With Moderate to Severe Alzheimer Disease

Adverse Effects

Page 11: Practical Approaches to Managing Patients With Moderate to Severe Alzheimer Disease

Medication Management

Page 12: Practical Approaches to Managing Patients With Moderate to Severe Alzheimer Disease

Combining Therapies

Page 13: Practical Approaches to Managing Patients With Moderate to Severe Alzheimer Disease

Medication Adherence

Page 14: Practical Approaches to Managing Patients With Moderate to Severe Alzheimer Disease

Managing Expectations

Page 15: Practical Approaches to Managing Patients With Moderate to Severe Alzheimer Disease

When Should You Stop Medications?

Page 16: Practical Approaches to Managing Patients With Moderate to Severe Alzheimer Disease

Polypharmacy

Page 17: Practical Approaches to Managing Patients With Moderate to Severe Alzheimer Disease

Managing Comorbidities

Page 18: Practical Approaches to Managing Patients With Moderate to Severe Alzheimer Disease

Managing Behavioral Problems

Page 19: Practical Approaches to Managing Patients With Moderate to Severe Alzheimer Disease

Managing Behavioral Problems (cont)

Page 20: Practical Approaches to Managing Patients With Moderate to Severe Alzheimer Disease

Caregiver Support

Page 21: Practical Approaches to Managing Patients With Moderate to Severe Alzheimer Disease

Caregiver Support (cont)

Page 22: Practical Approaches to Managing Patients With Moderate to Severe Alzheimer Disease

Patient Vignette: Part 2

Page 23: Practical Approaches to Managing Patients With Moderate to Severe Alzheimer Disease

Disease Progression

Page 24: Practical Approaches to Managing Patients With Moderate to Severe Alzheimer Disease

Advance Care Directives

Page 25: Practical Approaches to Managing Patients With Moderate to Severe Alzheimer Disease

End-Stage Care

Page 26: Practical Approaches to Managing Patients With Moderate to Severe Alzheimer Disease

Key Points


Tofacitinib for moderate to severe rheumatoid arthritis

Tofacitinib for moderate to severe rheumatoid arthritis

Education Specialist (Mild/Moderate or Moderate/Severe) Spec add-on Supervision...1 Education Specialist (Mild/Moderate or Moderate/Severe) Add-On Credential University Supervisor

Education Specialist (Mild/Moderate or Moderate/Severe) Spec add-on Supervision...1 Education Specialist (Mild/Moderate or Moderate/Severe) Add-On Credential University Supervisor

[F2] Management options for moderate to severe acne ...

[F2] Management options for moderate to severe acne ...

Clinical Guidebook 1. Introduction to Moderate to Severe ... · 3 Introduction to Moderate to Severe Acquired Brain Injury 1.1 Evidence-Based Practice The ERABI Clinical Guidebook

Clinical Guidebook 1. Introduction to Moderate to Severe ... · 3 Introduction to Moderate to Severe Acquired Brain Injury 1.1 Evidence-Based Practice The ERABI Clinical Guidebook

retnotbs.files.wordpress.com · High land Low land Coastal The severity of problem 1995 severe mild normal 1998 severe moderate mild 2003 severe moderate mild

retnotbs.files.wordpress.com · High land Low land Coastal The severity of problem 1995 severe mild normal 1998 severe moderate mild 2003 severe moderate mild

Moderate and severe hypoxia elicit divergent effects on ...

Moderate and severe hypoxia elicit divergent effects on ...

Dupilumab for treating moderate to severe atopic ...

Dupilumab for treating moderate to severe atopic ...

Dupilumab for treating moderate to severe atopic dermatitis

Dupilumab for treating moderate to severe atopic dermatitis

Secukinumab for treating moderate to severe plaque psoriasis 13 Skin/Z... · Secukinumab for treating moderate to severe plaque psoriasis Issued: July 2015 NICE technology appraisal

Secukinumab for treating moderate to severe plaque psoriasis 13 Skin/Z... · Secukinumab for treating moderate to severe plaque psoriasis Issued: July 2015 NICE technology appraisal

Moderate-to-severe eosinophilia induced by treatment with ...

Moderate-to-severe eosinophilia induced by treatment with ...

Preliminary Education Specialist Moderate/Severe Credential

Preliminary Education Specialist Moderate/Severe Credential

ORIGINAL ARTICLE Lebrikizumab in moderate-to-severe asthma ... · ORIGINAL ARTICLE Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies

ORIGINAL ARTICLE Lebrikizumab in moderate-to-severe asthma ... · ORIGINAL ARTICLE Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies

Biologic Therapies for Treatment of Moderate-to- Severe ...

Biologic Therapies for Treatment of Moderate-to- Severe ...

EXPERT COMMITTEE ON BIOLOGICAL STANDARDIZATION … · (CD), moderate to severe active ulcerative colitis (UC), moderate to severe plaque psoriasis, hidradenitis suppurativa, uveitis

EXPERT COMMITTEE ON BIOLOGICAL STANDARDIZATION … · (CD), moderate to severe active ulcerative colitis (UC), moderate to severe plaque psoriasis, hidradenitis suppurativa, uveitis

Moderate to Severe Pain: Novel Abuse Deterrent Formulation Technologies ... · THERAPEUTIC CLASS OVERVIEW Moderate to Severe Pain: Novel Abuse Deterrent Formulation Technologies and

Moderate to Severe Pain: Novel Abuse Deterrent Formulation Technologies ... · THERAPEUTIC CLASS OVERVIEW Moderate to Severe Pain: Novel Abuse Deterrent Formulation Technologies and

Tazobactam/piperacillin for moderate-to-severe …...1 Tazobactam/piperacillin for moderate-to-severe pneumonia in patients with risk for aspiration: comparison with imipenem/cilastatin

Tazobactam/piperacillin for moderate-to-severe …...1 Tazobactam/piperacillin for moderate-to-severe pneumonia in patients with risk for aspiration: comparison with imipenem/cilastatin

Treatment Algorithm for Mild and Moderate-to-Severe Ulcerative Colitis… · 2020. 2. 4. · Ulcerative colitis · Moderate to severe · Acute · Treatment Abstract Background: Patient

Treatment Algorithm for Mild and Moderate-to-Severe Ulcerative Colitis… · 2020. 2. 4. · Ulcerative colitis · Moderate to severe · Acute · Treatment Abstract Background: Patient

CHF Ec. MR Severe TR Moderate

CHF Ec. MR Severe TR Moderate

Management of Moderate and Severe Ischemic …...Management of Moderate and Severe Ischemic Mitral Regurgitation Vinod H. Thourani, MD Professor of Surgery Chair, Department of Cardiac

Management of Moderate and Severe Ischemic …...Management of Moderate and Severe Ischemic Mitral Regurgitation Vinod H. Thourani, MD Professor of Surgery Chair, Department of Cardiac

Baricitinib for moderate to severe rheumatoid arthritis

Baricitinib for moderate to severe rheumatoid arthritis